Abbott Laboratories is engaged in the discovery, development, manufacture, and sale of a line of health care products. Co. has four segments: Established Pharmaceutical Products, which includes a line of generic pharmaceuticals; Diagnostic Products, which includes a line of diagnostic systems and tests; Nutritional Products, which includes a line of pediatric and adult nutritional products; and Medical Devices, which includes a line of rhythm management, electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. The ABT YTD return is shown above.
The YTD Return on the ABT YTD return page and across the coverage universe of our site,
is a measure of the total return for a given investment year-to-date for the current calendar year
(up to the end of prior trading session). Arguably, choosing the current calendar year for a measurement
period is on the one hand completely arbitrary, but on the other hand a year-to-date look can be extremely
useful in the context of our country's tax system which taxes gains and income on a calendar year basis.
Thus, researching Year-To-Date Returns is good practice for investors — whether ABT YTD return or other benchmarks/peers
— and when doing so it is also important to factor in dividends, because a financial instrument's YTD return is
more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors
by performing the ABT YTD return calculation (with any dividends reinvested as applicable), and to provide a
coverage universe of many stocks and ETFs to be able to compare YTD returns.
|